ClinicalTrials.Veeva

Menu

Efficacy of Lower Limb Exercises on Overactive Bladder Symptoms in Patients With Multiple Sclerosis

S

San Donato Group (GSD)

Status

Unknown

Conditions

Muscle Strain
Multiple Sclerosis
Overactive Bladder Syndrome

Treatments

Other: Usual physical therapy
Other: Usual physical therapy+ strengthening of lower limbs muscles

Study type

Interventional

Funder types

Other

Identifiers

NCT03322748
OVERACT V1

Details and patient eligibility

About

The aim of the study (OVERACT_V1) is to verify if the isometric contraction of ankle plantarflexor and Hamstring muscles, induces a significant reduction of overactive bladder symptoms in patients with Multiple sclerosis.

Full description

The aim of the study (OVERACT_V1) is to verify if the isometric contraction of ankle plantarflexor and Hamstring muscles, induces a significant reduction of overactive bladder symptoms in patients with Multiple sclerosis. It's known that the electric stimulation of the Posterior Tibial nerve induces an improvement of overactive bladder symptoms through a modulation of spinal circuitry, which occurs with unknown mechanisms. The investigators' hypothesis is that the voluntary muscular activation may induce a modulation of the sacral root as long as the electric stimulation. 30 patients will be recruited within 2 years, since October 2017 through October 2019. This is a monocentric, randomized controlled , in single blind, not pharmacological study.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Multiple Sclerosis Patients
  • Urge score >=2
  • urinary daytime frequency >=8
  • stable overactive bladder symptoms for 6 months
  • MRC ( Medical Research Council) scale of ankle plantarflexors and hamstrings >=2
  • signed informed consensus

Exclusion criteria

  • FIM ( Functional Independence Measure) memory items <=4
  • impairment in registering bladder diary
  • inclusion in other experimental study
  • specific straightening during the suty period
  • PVR >= 200 ml ina single evaluation or PVR (post void residual) >=150 in 4 evaluation (twice a day for 2 consecutive days)
  • Urinary infections
  • concomitant urological disease
  • intrathecal baclofen pump
  • SANS (Stoller Afferent Nerve Stimulation)
  • modification of therapy for overactive bladder symptoms within three months before entering the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Experimental group
Experimental group
Description:
Usual physical therapy+ strengthening of lower limbs muscles
Treatment:
Other: Usual physical therapy+ strengthening of lower limbs muscles
Control group
Other group
Description:
Usual physical therapy
Treatment:
Other: Usual physical therapy

Trial contacts and locations

1

Loading...

Central trial contact

Valentina Grazioli, PT; Giancarlo Comi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems